Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 08/14/2024 at 13:05, 3 months 7 days ago

Moderna and Coursera Launch Free Course on mRNA Technology

MRNA Technology Online Education Therapeutics Workforce Readiness STEM Skills
PRESS RELEASE

published on 08/14/2024 at 13:00, 3 months 7 days ago

Moderna and Coursera Launch Free Course on mRNA Technology
Moderna and Coursera partner to offer free course 'mRNAs as Medicines' to enhance understanding of mRNA technology and its applications in medicine, supporting STEM education globally

MRNA Technology Moderna STEM Education Coursera MRNAs As Medicines
BRIEF

published on 08/01/2024 at 12:35, 3 months 20 days ago

Moderna Reports Second Quarter 2024 Financial Results and Business Updates

Financial Results Q2 2024 Moderna Vaccine MRNA
PRESS RELEASE

published on 08/01/2024 at 12:30, 3 months 20 days ago

Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q2 revenues of $241 million, GAAP net loss of $1.3 billion. Updates 2024 financial framework and expects product sales of $3.0-$3.5 billion. Announces key developments in vaccines and financial results

Financial Framework Moderna Business Updates Q2 Revenues Vaccine Approvals
BRIEF

published on 07/23/2024 at 13:05, 3 months 29 days ago

David Rubenstein Joins Moderna's Board of Directors

Biotechnology David Rubenstein Moderna Board Robert Langer Stephen Berenson
PRESS RELEASE

published on 07/23/2024 at 13:00, 3 months 29 days ago

David Rubenstein Joins Moderna's Board of Directors
David M. Rubenstein joins Moderna's Board of Directors, replacing retiring directors Robert Langer and Stephen Berenson. Rubenstein brings vast investor and policy expertise from The Carlyle Group

Board Of Directors Moderna David M. Rubenstein The Carlyle Group Global Policy Expertise
BRIEF

published on 07/10/2024 at 13:05, 4 months 11 days ago

Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024

Financial Results Conference Call Webcast Q2 2024 Moderna
PRESS RELEASE

published on 07/10/2024 at 13:00, 4 months 11 days ago

Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
Moderna, Inc. will host a live conference call and webcast on August 1, 2024, reporting its second quarter financial results and giving a corporate update. Moderna leads in mRNA medicine, developing treatments and vaccines for various diseases

Financial Results Moderna Inc. MRNA Medicine Vaccines Live Conference Call
BRIEF

published on 07/02/2024 at 13:35, 4 months 19 days ago

Moderna Secures $176 Million for mRNA-Based Influenza Vaccine Development

Moderna Vaccine MRNA Influenza BARDA
PRESS RELEASE

published on 07/02/2024 at 13:30, 4 months 19 days ago

Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
Moderna, Inc. awarded $176 million to accelerate mRNA-based pandemic influenza vaccine development through a Consortium funded by BARDA. Collaboration aims to enhance global public health preparedness

Moderna Inc. MRNA Technology BARDA Pandemic Influenza Vaccine Global Public Health

Accesswire

Published on 11/22/2024 at 00:00, 5 hours 26 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 7 hours 21 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 7 hours 36 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 9 hours 11 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 9 hours 16 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 10 hours 25 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 10 hours 50 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 11 hours 27 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 11 hours 34 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 11 hours 35 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 22 hours 28 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 10 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 11 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 11 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 21 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE